CYVNY — Opthea Ltd
—
OTC ·
Health Care ·
Biotechnology ·
CIK 1815620 ·
Australia
Last close
—
Market Cap
—
52W High
—
52W Low
—
ADV30
—
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Dec 2024 | — | — | — | — | 145,770,000 | 131,916,000 | 314,475,000 |
Balance + Analyst (yfinance extras)
Retained Earnings
$-711,622,000
Inventory
—
Receivables
$7,984,000
ST Investments
—
EBIT TTM
—
Pretax Income TTM
—
Interest Exp TTM
—
Analysts
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Jun 2025 | 25,000 | -152,312,000 | -162,791,000 | 56,799,000 | 257,868,000 | — | — |
| Jun 2024 | 125,000 | -191,842,000 | -220,242,000 | 188,791,000 | 264,601,000 | — | -161,015,354 |
| Jun 2023 | 108,000 | -150,025,000 | -142,521,000 | 98,641,319 | 104,494,497 | — | -120,608,379 |
| Jun 2022 | 90,683 | -96,537,963 | -92,817,371 | 60,046,819 | 12,069,675 | — | -71,334,952 |
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| AMGN | AMGEN INC | $203.07B | $376.26 | — |
| GILD | GILEAD SCIENCES, INC. | $162.05B | $130.52 | — |
| ARGX | ARGENX SE | $55.61B | $888.82 | — |
| RVMD | Revolution Medicines, Inc. | $39.98B | $188.07 | — |
| BIIB | BIOGEN INC. | $29.55B | $200.14 | — |
Recent Insider Activity
No insider activity indexed for this ticker.